| Before intervention | After intervention | p-value* | Changes | p-value* |
---|---|---|---|---|---|
Serum 25(OH)D (ng/mL) | Â | Â | Â | Â | Â |
Intervention | 14.08 ± 5.15 | 19.1 ± 5.69 |  < 0.001 | 5.02 |  < 0.001 |
Control | 14.1 ± 5.04 | 13.89 ± 5.85 | 0.71 | 0.21 |  |
hs-CRP (mg/L) | Â | Â | Â | Â | Â |
Intervention | 1.1 (0–3.25) | 1.15 (0.4–2.92) | 0.16 | − 0.25 | 0.77 |
Control | 1.15 (0.1–3.75) | 1.4 (0.5–4.2) | 0.75 | 0.25 |  |
WBC (billion cells/L) | Â | Â | Â | Â | Â |
Intervention | 6.56 ± 1.57 | 6.35 ± 1.68 | 0.099 | − 0.05 | 0.37 |
Control | 6.64 ± 1.5 | 6.57 ± 1.35 | 0.64 | 0.07 |  |
Neutrophil (percent) | Â | Â | Â | 7.37 | Â |
Intervention | 61.75 ± 6.57 | 54.38 ± 5.44 |  < 0.001 | 1.06 | 0.5 |
Control | 58.8 ± 6.97 | 57.74 ± 6.22 | 0.12 |  |  |
Lymphocyte (percent) | Â | Â | Â | 0.45 | Â |
Intervention | 35.97 ± 7.2 | 35.52 ± 7.19 | 0.5 | − 0.29 | 0.75 |
Control | 35.45 ± 6.97 | 35.74 ± 6.42 | 0.58 |  |  |
Platelets (billion/L) | Â | Â | Â | Â | Â |
Intervention | 267.96 ± 35.01 | 214.82 ± 36.77 |  < 0.001 | 53.14 | 0.49 |
Control | 251.88 ± 56.33 | 236.42 ± 47.96 | 0.001 | 15.46 |  |
RDW (percent) | Â | Â | Â | Â | Â |
Intervention | 13.24 ± 0.78 | 11.61 ± 0.97 |  < 0.001 | 1.63 | 0.089 |
Control | 13.12 ± 0.83 | 13.29 ± 1.03 | 0.066 | − 0.17 |  |
NLR | Â | Â | Â | Â | Â |
Intervention | 1.81 ± 0.51 | 1.62 ± 0.51 |  < 0.001 | 0.19 | 0.39 |
Control | 1.76 ± 0.56 | 1.68 ± 0.45 | 0.1 | 0.08 |  |
PLR | Â | Â | Â | Â | Â |
Intervention | 7.78 ± 2.12 | 6.35 ± 1.98 |  < 0.001 | 1.43 | 0.48 |
Control | 7.44 ± 2.64 | 6.88 ± 2.25 | 0.004 | 0.56 |  |
RPR | Â | Â | Â | Â | Â |
Intervention | 0.055 ± 0.1 | 0.05 ± 0.007 |  < 0.001 | 0.005 | 0.98 |
Control | 0.058 ± 0.01 | 0.054 ± 0.013 | 0.003 | 0.004 |  |